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doi:10.1016/j.kjms.2010.04.002Abstract Nodular glomerulopathy is a pattern of glomerular injury observed under light
microscopy that could result from several diseases presented as nephrotic syndrome clinically.
Compared with venous thrombosis, cerebral infarction resulting from arterial thrombosis is
relatively rare in these patients. We report an interesting case of severe nephrotic syndrome
complicated with acute cerebral infarction, and renal biopsy revealed nodular glomerulopathy
under light microscopy. Immunofluorescent staining was positive for l light chain (predomi-
nant) and k light chain, mainly in mesangial areas, and electron microscopic study showed
massive amorphous acellular deposits also in mesangial areas with some local extension to sub-
endothelial space. Congo red stain gave negative results under polarized light. The case was
concluded as an atypical presentation of light chain deposition disease both pathologically
and clinically.
摘要 結節性腎絲球病變為腎絲球遭受傷害的所表現的一種形態，可能由某些特定疾病所導致，
臨床表現為腎病症候群，相較於較常見的靜脈栓塞; 以中風來表現的急性動脈梗塞是相對少見
的。我們報告一位嚴重腎病症候群併發急性腦梗塞的病人，腎臟切片結果於光學顯微鏡下顯示為
結節性腎絲球病變的型態，螢光染色顯示免疫l和k輕鏈陽性反應，而以l輕鏈為主，主要沉積於
腎間質區，電子顯微鏡下顯示大量免疫複合體沉積於腎間質區，部分延伸至腎絲球血管下。剛果
紅染色於偏光鏡下為陰性反應，病理上確診為免疫球蛋白輕鏈沉積病變，其沉積型態與以往報告
過的不同，於臨床上和病理上皆為較特殊的表現。
Copyright ª 2011, Elsevier Taiwan LLC. All rights reserved.ephrology, Department of Medicine, Kaohsiung Medical University, 100 Tzyou First Road, Kaohsiung
tw (H.-C. Chen).
vier Taiwan LLC. All rights reserved.
Figure 1. Light microscopy showed negative PAS stain [(A) PAS stain, 400] and negative silver stain [(B) silver stain, 400]
amorphous, acellular deposits in mesangial area (arrows), with further narrowing of capillary lumen (arrow head).
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A 72-year-old female patient first visited our clinic in
September 2007 because of edema of lower legs and foamy
urine for more than 2 months. She denied any systemic
diseases except cholecystectomy 15 years ago for gall
bladder stones.
Her blood pressure was 126/90 mmHg, pulse rate was 84
beats/min, bodyweight was 52 kg, and physical examination
revealed only a moderate degree of edema over the lower
extremities. Serial examination showed serum albumin of
1.80 g/dL, serum cholesterol and triglyceride of 556/
349 mg/dL, and daily protein loss of 12 g. Other laboratory
studies showed the following: blood glucose, 90 mg/dL;
blood urea nitrogen, 14 mg/dL; serum creatinine, 0.91 mg/
dL; phosphate, 3.9 mg/dL; ionized calcium, 4.84 mg/dL;
aspartate transaminase, 28 U/L; alanine transaminase,
15 U/L; sodium, 138 mmol/L; potassium, 4.3 mmol/L; and
uric acid, 4.8 mg/dL. Hematocrit was 39.1%, platelet count
was 238,000/uL, and white blood cell count was 6,080/uL.
Other findings included serum immunoglobulin gamma (IgG),
396 mg/dL; immunoglobulin A (IgA), 419 mg/dL; immuno-
globulin M (IgM), 104 mg/dL; C3, 122 mg/dL; and C4,
29.1 mg/dL. Serum antinuclear antibody was negative.
Prothrombin time was 10.1/11.1 s, and partial thrombo-
plastin time was 27.9/29.5. Both hepatitis B surface antigen
(HBsAg) and anti-hepatitis C (HCV) antibody were negative.
Ultrasonographic examination revealed kidneys of normal
size with slightly irregular surface. Renal biopsy wasFigure 2. Immunofluorescence study revealed a strong positive r
400] and weak positive reaction for k light chain [(B) anti-k, 400performed and, under light microscopic examination, the
renal core was found to contain 13 glomeruli. Most glomeruli
showed increased amorphous acellular substance in the
glomerularmesangium,without significant tubulointerstitial
changes (Fig. 1). Immunofluorescence (IF) study showed
negative staining for IgG, IgM, IgA, C3, C4, andfibrinogen, but
positive staining for l light chain (predominant) and k light
chain, mainly in mesangial areas (Fig. 2).
Electron microscopic (EM) study showed massive amor-
phous acellular deposits in mesangial areas with some local
extension to subendothelial space, causing relative nar-
rowing of the capillary lumen but without mesangial or
endothelial proliferation. The glomerular basement
membrane (GBM) was not thickened, and the foot processes
were only focally effaced. Some lipid droplets could be
seen in podocytes, compatible with severe proteinuria in
clinical presentation (Fig. 3A and B). Under high-power
examination, poorly organized materials and scattered
coarse granules (Fig. 3C) were found, which, by definition,
could only be classified as monoclonal immunoglobulin
deposition disease, and was further classified as light chain
deposit disease (LCDD) according to the immunofluorescent
staining of light chain.
Albumin infusion along with diuretics (oral furosemide
40 mg/d and spironolactone 25 mg, three times a day) was
given for symptomatic therapy of edema. The response was
fair with urinary output of 1200 mL/d and a decrease in
body weight of 6 kg within 1 week. Pentoxifylline, 400 mg
twice daily, and rosuvastatin, 10 mg once daily, were alsoeaction of l light chain with mesangial distribution [(A) anti-l,
].
Figure 3. Electron microscopy showed compatible amorphous deposits in mesangial area extending to capillary loops with
prominent subendothelial distribution [(A) 4,000, (B) 30,000]. No fibrillar organization deposit was found [(C) 100,000].
Figure 4. Diffusion-weighted magnetic resonance imaging
study showed high signal intensity on left frontal lobe,
compatible with acute cerebral infarction.
Nodular glomerulopathy and cerebral infarction 41given for prevention of thromboembolism and control of
hyperlipidemia.
Unfortunately, she suffered acute onset of mutism and
weakness over right limbs after a bath at home several days
later. Inability to name things or even family members was
observed. Owing to progressive worsening, she was sent to
hospital again. Serial image study later revealed acute
infarction over the left frontal lobe (Fig. 4), and her body
weight was 48 kg. The clinical course stabilized after
holding diuretics and giving hydration. However, Broca’s
aphasia and mild right limb weakness remained, and
further rehabilitation was needed.
We carried out both serum and urine immunofixation
electrophoresis and bone marrow aspiration for excluding
possible multiple myeloma, and only nonspecific findings
with plasma cells of less than 10% was found. Prednisolone
(1 mg/kg/d) was given, and the daily protein loss decreased
to 5.2 g. Aspirin was also given for prophylaxis of further
thromboembolic events.
Discussion
This is an unusual case of nodular glomerulopathy compli-
catedwith acute cerebral infarction.Many factors contribute
to hypercoagulability of nephrotic syndrome. They included
the following: (1) decreased fibrinolytic activity because of
marked urinary loss of related proteins (e.g. plasminogen)
[1]; (2) compensatory increased highemolecular weight
procoagulatory cofactors (e.g. Factors V, VII, and VIII)
because of increased urinary loss of lowemolecular weight
factors; and (3) dysfunction or depletion of regulatory
proteins of coagulation, such as Antithrombin III; debates
exist although normal or high level have all been reported [2].However, arterial occlusion is still relatively rare compared
with venous thrombosis in adults with nephrotic syndrome
and has been reported only sporadically [3,4]. As reviewed
from the literature, the most important predisposing factors
included severe hypoalbuminemia (<2.0 g/dL) and/or
diuretics used; histological evidence of membranous
nephropathy was frequently recognized as a predominant
Table 1 Characteristics of common glomerular deposition diseases
Diseases Etiology Congo red
stain
Light microscopic features Immunofluorescence Electron microscopy
Diabetic nodular
sclerosis
Diabetes mellitus Negative Mesangial expansion and
GBM thickening
Arterial hyalization、
Interstitial fibrosis
Glomerulomegaly
Nodular sclerosis with PAS
stain (þ) and silver stain (þ)
Linear IgG along GBM
Nonspecific trapping
of IgM and C3 in
sclerotic area
Homogenous thickening of GBM,
occasional electron-dense
hyaline material in mesangium
Amyloidosis Lymphoproliferative
disease
Secondary to chronic
inflammation
Positive Acellular amorphous pink
hyaline material
Deposition mainly in
mesangial area
Occasionally feathery spikes
because of GBM reaction in
peripheral capillary loop
Nodular lesion with PAS
stain () and silver stain ()
Smudgy deposition
of light chain in
mesangial area
(AL amyloidosis)
Predominant l
light chain
Organized, randomly oriented
nonbranching fibrils; diameter,
8e12 nm
Fibrillary
glomerulonephritis
Lymphoproliferative
disease
Negative Mesangial proliferation or
diffuse endocapillary proliferation,
occasionally with crescents,
might GBM splitting
Nodular lesion with PAS
stain (þ) and silver stain (þ)
Predominant IgG and C3,
chunky segmental
staining along GBM and
mesangium
Organized randomly arranged fibrils;
diameter average, 20e22 nm
Immunotactoid
glomerulonephropathy
Lymphoproliferative
disease
Negative Mild mesangial hypercellularity,
might cause GBM splitting. Nodular
lesion with PAS stain (þ) and
silver stain (þ)
Predominant IgG and C3,
chunky、irregular along
capillary loops and in the
mesangium
Regularly, parallelly arranged fibrils:
diameter, 30e50 nm
Monoclonal
immunoglobulin
deposition disease
Lymphoproliferative
disease
Negative Nodular glomerulosclerosis,
various degrees of
mesangial proliferation and expansion,
PAS stain (þ) and silver stain ()
Tubular basement
membrane and GBM
linear staining, usually k
light chain
Nonorganized granular deposits,
usually along subendothelial region
MPGN、Lupus nephritis Infection、autoimmune、
idiopathic
Negative Mesangial hypercellularity
and mesangial matrix expansion,
GBM duplication
Nodular lesion with PAS
stain (þ) and silver stain (þ)
C3, C1q, IgG, IgM
deposition in capillary
walls and mesangium
Nonorganized subendothelial
electron-dense deposits
Bold term represents only amyloid fibrils have affinity with congo red stain.
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Nodular glomerulopathy and cerebral infarction 43type of nephrotic syndrome leading to thrombotic events,
although other types of glomerulopathy (e.g.minimal change
disease、focal segmental sclerosis) have been noticed.
There has been no case report on cerebral infarction
complication in patients with LCDD-related nephrotic
syndrome; perhaps, because it is a relatively rare cause of
nephrotic syndrome, and the renal damage is heteroge-
neous, depending on the sites of light chain deposits.
Patients with predominant tubular deposition may present
with renal dysfunction and only mild proteinuria, whereas
those with predominant glomerular deposition may present
with marked protein loss because of severe glomerular
destruction, such as that in our case. Our patient had
severe hypoalbuminemia (1.8 g/dL) and relative hemo-
concentration (39.1%) at the time of initial therapy. Prompt
response to diuretic use and rapid body weight reduction
were noted, which may possibly lead to the stroke event, as
watershed infarction pattern in left hemisphere (Fig. 4), in
spite of using antiplatelet agent. Hyperviscosity syndrome
because of dysproteinemia of Waldenstro¨m’s macroglobu-
linemia is also well known, but whether light chain
paraproteins, as in our patient, are associated with the
disorder is not known. Routine aggressive prophylactic
anticoagulation therapies in such high-risk patients,
including subcutaneous lowemolecular weight or synthetic
heparins, aspirin, dipyridamole, have been suggested. They
should be justified with the risk of bleeding being consid-
ered and should be convenient for outpatient use.
Moreover, the histological findings on the kidneys of our
patient are quiet interesting and worth further discussion.
Monoclonal immunoglobulin deposition disease is an entity
of diseases first described in the late 1950s, with nodular
glomerular lesions resembling those of diabetic nephro-
sclerosis, but without fibrillar organization and Congo red
affinity. These diseases include LCDD, heavy chain deposit
disease (HCDD), and light and heavy chain deposit disease
(LHCDD) [5], and must be differentiated from other
“glomerular deposition diseases” [6], such as amyloidosis,
and diabetic nephrosclerosis [7,8].
As summarized in Table 1, we could use Congo red,
periodic acid-Schiff stain (PAS), and silver stains under light
microscopy to differentiate nodular glomerulopathy. For
example, the mesangial nodules could be stained with PAS
and silver stains in diabetics, as may also be observed in
membranoproliferative glomerulonephritis (MPGN), fibril-
lary glomerulopathy, and immunotactoid glomerulopathy
patients. On the other hand, deposits in LCDD tend to be
PAS stain positive and silver stain negative. Amyloid fibrils
do not react with either PAS or silver stain. However,
because of its special conformation of proteinaceous fibrils
with b-sheet structure, it is resistant to proteolysis and
shows affinity only to Congo red dye. It would show apple
green birefringence under polarized light [9].
IF study could reveal further the characteristics of the
deposits. Both l and k light chains are the precursor proteins
of AL (it refers to amyloid light chain) amyloidosis and LCDD.
However, l light chain tends to form amyloid fibrils and is,
thus, the dominant staining in AL amyloidosis. Instead, k
light chain is the dominant staining in LCDD. Finally, EM
could help distinguish the ultrastructure of deposits, which
varies with the characteristics of precursor proteins. In
amyloidosis, fibrillary glomerulopathy, and immunotactoidglomerulopathy, paraproteins form fibrillar organization and
can be further divided according to their diameters (Table
1). Others do not form definite organized deposits, and
fine granular deposits were found along the GBM in LCDD.
Our case of LCDD shared many features with AL amyloid-
osis. First, LCDD usually shows nodular glomerulopathy
positive for PAS stain but negative for silver stain. However,
the amorphous deposits in our case were negative for both
PAS and silver stains. Second, LCDD usually shows a predom-
inant k light chain staining (k:lZ 3:2), instead of l light
chain staining, as in our case, under immunofluorescent
staining. Third, the electron-dense deposits in LCDD are
usually distributed granularly along the GBM and tubular
basement membrane and to a lesser extent in mesangial
areas, unlike those in our case, which showed prominent
smudgy mesangial staining typical of amyloid deposits. Both
Congo red negative staining and absence of fibrillar organi-
zation of the deposits pointed to the final diagnosis of LCDD.
Discrepancy between IF and EM findings in LCDD has
been reported [10,11]. It may be a positive IF staining
without deposits found on EM, because of focal distribution
and small sample size, or there may be typical deposits
found on EM but without IF staining because of loss of
antigenic site [11]. The diversity of immunoglobulin struc-
tures that further undergo degradation and modification in
tissue may also contribute to the aforementioned finding.
However, our patient had dysproteinemia with compatible
light chain deposition on both IF and EM studies, with
mosaic features between AL amyloidosis and LCDD, which
have never been reported.
Treatment of LCDD is aimed at ameliorating immuno-
globulin production and the subsequent organ deposition. It
is reasonable to give intensive chemotherapy or combined
therapy with bone marrow transplantation if a comorbid
malignancy was found. Multiple myeloma has been repor-
ted in up to 40% of cases of LCDD [12]. However, in most
patients with LCDD, who are not associated with malig-
nancy, therapy is controversial and data are limited [13].
Age and serum creatinine levels at presentation have been
found to be the major predictors of prognosis, and recur-
rence is frequent after renal transplantation [14]. There-
fore, renal transplantation could only be considered when
the disease was well controlled. Owing to old age and
comorbidity in our patient, we gave steroid alone, which
seemed to be effective and achieved a decrease in
proteinuria. Further studies are needed to determine the
treatment of choice.
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